Ovarian cancer (OC) remains one of the leading causes of gynecological cancer related. Despite its histological and genetic heterogeneity, standard treatment has remained largely unchanged, relying on cytoreductive surgery followed by platinum-taxol chemotherapy. Although the introduction of PARP in...
ORGANISM(S): Homo sapiens (Human)
